Charles Olson
Director/Board Member at EDESA BIOTECH, INC.
Net worth: - $ as of 2024-04-29
Charles Olson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EDESA BIOTECH, INC. | Director/Board Member | 2023-05-22 | - |
Alkira Therapeutics, Inc.
 Alkira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Anthera Pharmaceuticals, Inc., Alkira Therapeutics, Inc. develops and commercializes clinical pharmaceutical products. The company is based in Hayward, CA. | President | - | - |
Career history of Charles Olson
Former positions of Charles Olson
| Companies | Position | Start | End |
|---|---|---|---|
| DENDREON CORPORATION | Chief Operating Officer | 2021-08-31 | 2023-03-31 |
| APPLIED MOLECULAR TRANSPORT INC. | Chief Operating Officer | 2019-08-31 | 2022-05-15 |
| Corporate Officer/Principal | 2017-08-31 | 2019-07-31 | |
| ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2016-01-05 | 2017-07-12 |
Ansun Biopharma, Inc.
 Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | - | - |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - | - |
| ░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Training of Charles Olson
| Westmont College | Undergraduate Degree |
| University of California, Santa Barbara | Graduate Degree |
| Hawthorn University | Doctorate Degree |
Statistics
International
| United States | 13 |
| Canada | 3 |
Operational
| Corporate Officer/Principal | 6 |
| Director/Board Member | 2 |
| Chief Operating Officer | 2 |
Sectoral
| Health Technology | 12 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| EDESA BIOTECH, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Alkira Therapeutics, Inc.
Alkira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Anthera Pharmaceuticals, Inc., Alkira Therapeutics, Inc. develops and commercializes clinical pharmaceutical products. The company is based in Hayward, CA. | Health Technology |
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Charles Olson
- Experience
